Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
The latest trading day saw Boston Scientific (BSX) settling at $76.31, representing a +0.16% change from its previous close.
Boston Scientific Buys Silk Road Medical for $1.26 Billion
Shares of Silk Road Medical (SILK) soared in intraday trading Tuesday after Boston Scientific (BSX) announced it was buying the medical device maker for about $1.26 billion.
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal
Tuesday, Boston Scientific Corporation BSX agreed to acquire Silk Road Medical Inc SILK for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.
Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific.
Boston Scientific will pay $27.50 a share, or $1.16 billion, for Silk Road Medical.
Boston Scientific to buy Silk Road Medical in $1.16 billion deal
Boston Scientific will acquire medical device maker Silk Road Medical in a $1.16 billion deal, the companies said on Tuesday.
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note
In the most recent trading session, Boston Scientific (BSX) closed at $77.41, indicating a +0.34% shift from the previous trading day.
Boston Scientific (BSX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the latest trading session, Boston Scientific (BSX) closed at $75.57, marking a +0.76% move from the previous day.
Here's Why You Should Buy Boston Scientific (BSX) Stock Now
Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.
Boston Scientific (BSX) Up 1.5% Since Last Earnings Report: Can It Continue?
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?
Boston Scientific (BSX) Rides on Emerging Markets, MedSurg
Boston Scientific's (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and pulmonary treatment options.
What Drove A Nearly 2x Rise In Boston Scientific's Profits?
Boston Scientific Boston Scientific (NYSE: BSX) saw its net income expand by $0.9 billion or 145% y-o-y to $1.6 billion in 2023. This can primarily be attributed to an expansion of its operating margin and lower taxes.
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.
